These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23402236

  • 1. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Feb 04; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 3. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J, Kottalgi M, Cirra VR, Shah N, Kamboj R.
    Am J Ther; 2012 Nov 04; 19(6):e182-5. PubMed ID: 23154229
    [Abstract] [Full Text] [Related]

  • 4. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 04; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 5. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Mar 04; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 6. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J, Pike G, Keighley-Jones L, Nash MJ.
    Am J Med; 2013 Aug 04; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract] [Full Text] [Related]

  • 7. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
    Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM.
    Thromb Haemost; 2012 Sep 04; 108(3):583-5. PubMed ID: 22782645
    [No Abstract] [Full Text] [Related]

  • 8. Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
    Gunes F, Asik M, Temiz A, Binnetoglu E, Sen H, Bilen Oİ, Akbal E, Adam G, Ukinc K.
    Wien Klin Wochenschr; 2014 Jan 04; 126(1-2):62-3. PubMed ID: 24240609
    [No Abstract] [Full Text] [Related]

  • 9. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV, Zateĭshchikov DA.
    Kardiologiia; 2014 Jan 04; 54(2):79-85. PubMed ID: 24888206
    [No Abstract] [Full Text] [Related]

  • 10. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
    Singh T, Maw TT, Henry BL, Pastor-Soler NM, Unruh ML, Hallows KR, Nolin TD.
    Clin J Am Soc Nephrol; 2013 Sep 04; 8(9):1533-9. PubMed ID: 23704302
    [Abstract] [Full Text] [Related]

  • 11. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
    Gagliardi L, Guerbaai RA, Marlière S, Bouvaist H, Ennezat PV.
    Int J Cardiol; 2014 Aug 20; 175(3):571-2. PubMed ID: 24861253
    [No Abstract] [Full Text] [Related]

  • 12. Emergency subtotal colectomy in a Jehovah's Witness with massive lower gastrointestinal bleeding: challenges encountered and lessons learned.
    Raman SR, Parithivel VS, Cosgrove JM.
    Am J Crit Care; 2011 Mar 20; 20(2):179, 176-8. PubMed ID: 21362723
    [Abstract] [Full Text] [Related]

  • 13. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 20; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P, Duraj I, Szlagowska L, Ciastkowska A, Broncel M.
    Pol Merkur Lekarski; 2014 Nov 20; 37(221):261-4. PubMed ID: 25546985
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
    Ross B, Miller MA, Ditch K, Tran M.
    J Med Toxicol; 2014 Jun 20; 10(2):223-8. PubMed ID: 24385325
    [Abstract] [Full Text] [Related]

  • 16. [Exfoliative esophagitis while taking dabigatran].
    Scheppach W, Meesmann M.
    Dtsch Med Wochenschr; 2015 Apr 20; 140(7):515-8. PubMed ID: 25826037
    [Abstract] [Full Text] [Related]

  • 17. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J, Stöllberger C, Paul G, Bastovansky A.
    Cardiovasc Ther; 2013 Dec 20; 31(6):e111-4. PubMed ID: 24279385
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK, Kouides PA.
    Ann Pharmacother; 2012 Apr 20; 46(4):e10. PubMed ID: 22496474
    [Abstract] [Full Text] [Related]

  • 19. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.
    Bytzer P, Connolly SJ, Yang S, Ezekowitz M, Formella S, Reilly PA, Aisenberg J.
    Clin Gastroenterol Hepatol; 2013 Mar 20; 11(3):246-52.e1-5. PubMed ID: 23103906
    [Abstract] [Full Text] [Related]

  • 20. Extensive postoperative ecchymosis in a patient taking dabigatran.
    Wagner CA, Oberoi N, Ahluwalia PK.
    J Minim Invasive Gynecol; 2013 Mar 20; 20(1):127-30. PubMed ID: 23312256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.